Samsara BioCapital, L.P., 10% Owner at Mineralys Therapeutics, Inc. (MLYS), bought 600,000 shares at $13.50 ($8.1M) on 2025-03-13, disclosed to the SEC on 2025-03-17.
Open-market purchase of $8.1M MLYS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| GRPH | BUY | 2021-12-20 | $455K | — | Filing → |
| GRPH | BUY | 2021-10-15 | $668K | — | Filing → |